Papillary carcinoma of the breast: Characteristics and classification

American Surgeon

Volumn 69, Issue 5, 2003, Pages 400-403

  Bansidhar, Brian J ^a   Garguilo, Gerard A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

ADJUVANT THERAPY; AGED; ARTICLE; BREAST TUMOR; CASE REPORT; CLASSIFICATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RADIOTHERAPY, ADJUVANT; TAMOXIFEN;

EID: 0038010549     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rosen P. Breast Pathology. New York: Lippincott-Raven, 1997, pp 335-353
2. Foote FW Jr, Stewart SW. A histologic classification of carcinoma of the breast. Surgery 1946;19:74-99.
3. Greenfield LJ, Mulholland M, Oldham K, et al. Surgery: Scientific Principles and Practice. Philadelphia: Lippincott-Raven, 1997, pp 1397-1413
4. Fisher ER, Palekar AS, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol 1980;73:313-320 (Pubitemid 10124564)
5. Carter D, Orr SL, Merino MF. Intracystic papillary carcinoma of the breast after mastectomy, radiotherapy, or excisional biopsy alone. Cancer 1983;52:14-19
6. Kraus FT, Neubecker RD. The differential diagnosis of papillary tumors of the breast. Cancer 1962;15:444-455
7. World Health Organization. Histological Typing Of Breast Tumors, 2nd Ed. International Histological Classification of Tumors, No.2. Geneva: World Health Organization, 1981, p 19.
8. Leal C, Costa I, Fonseca D, et al. Intracystic (encysted) papillary carcinoma of the breast: A clinical, pathological, and immunohistochemical study. Hum Pathol 1998;29:1097-1104 (Pubitemid 28467530)
9. Saddik M, Lai R. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast. J Clin Pathol 1999;52:862-864 (Pubitemid 29524955)
10. McCullough GL, Evans AJ, Yeoman L, et al. Radiological features of papillary carcinoma of the breast. Clin Radiol 1997;52:865-868
11. Saddik M, Lai R, Medeiros J, McCourty A. Differential expression of cyclin D1 in breast papillary carcinomas and benign papillomas. Arch Pathol Lab Med 1999;123:152-156
12. Tresserra F, Grases PJ, Fabregas R, et al. Invasive micropapillary carcinoma: Distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol 1999;20:205-208 (Pubitemid 29286491)
13. Lanzafame S, Emmanuelle C, Torrisi A, Magro G. Correlated expression of BCL-2 protein, estrogen receptor, cathepsin D and low growth fraction (PCNA) in intracystic papillary breast carcinoma. Pathol Res Pract 1998;194:541-547 (Pubitemid 28430073)
14. Bloodgood JC. Benign lesions of the female breast for which operation is not indicated. JAMA 1922;78:859-863
15. Harris KP, Faliakou EC, Exon DJ, et al. Treatment and outcomes of intracystic papillary carcinoma. Br J Surg 1999;86:1274.